Published in Lab Law Weekly, December 15th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Biovest International.
Report 1: A majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., (ABPI), Biovest International, Inc., (BVTI) has launched its AutovaxID automated cell culture device for commercial sale.
AutovaxID is a fully automated, reusable instrument that employs a fully disposable, closed-system cell-growth chamber incorporating a hollow-fiber cell-growth cartridge. This unique bioreactor replaces conventional stainless steel, glass, and plastic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.